banner

Posts tagged as: True 2 Beauty news back to homepage

True 2 Beauty Sells Libigrow Brand for $425,000 True 2 Beauty Sells Libigrow Brand for $425,000(0)

In a re-direct to focus its business on female-oriented products, Los Angeles-based True 2 Beauty, Inc. (Pink Sheets:TRTB) has sold its Libigrow brand for a net purchase price of $425,000. The buyer is a privately-held company owned by prior management of True 2 Beauty. Read More

Reverse Split Announced by True 2 Beauty Reverse Split Announced by True 2 Beauty(0)

Early this morning, True 2 Beauty, Inc. (Pink Sheets:TRTB) announced a 1 for 100 reverse stock split of its common stock.  The split’s effective date is November 1, 2011.  The Company cites the reason for the split as to “eliminate a restrictively low price of pennies per share which prevented many investors from purchasing its shares through broker-dealers.”

The split will take the number of issued and outstanding shares of TRTB from 248,017,937 to 2,480,179.  The number of authorized shares will drop from 500 million to 200 million.



True 2 Beauty, Inc. is a leading distributor of male & female lifestyle ingestible products and health & beauty accessories including pills, liquid products, and semi-durable goods in the United States. The Company’s line of current products includes Libigrow, Libigirl, Blue Diamond, Pink Diamond, Energy Shots, Relaxation Drinks, EZ Curler Curling Roller, and Naked Vapor Electronic Cigarettes.

True 2 Beauty (TRTB) Stock Quote and News:


Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/?page_id=190.



Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.